The University of Chicago and Deerfield Management launch Hyde Park Discovery to accelerate ...
The University of Chicago and healthcare investment firm Deerfield Management announced today the launch of Hyde Park ...
The Beat: UChicago teams with Deerfield Management, Rhaeos joins Fulton Market
This was the case for clean chemistry startup Mattiq, which recently opened its new office at 400 N. Aberdeen, one of two ...
University of Chicago enters $130M partnership to develop new drugs
The University of Chicago is partnering with a health care investment firm that has pledged up to $130 million to help turn ...
The University of Chicago Chronicle2 天
Collaboration to provide up to $130 million to fuel drug discovery, development at UChicago
Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...
TMCnet2 天
The University of Chicago and Deerfield Management launch Hyde Park Discovery to accelerate ...
CHICAGO and NEW YORK, Jan. 28, 2025 /PRNewswire/ -- The University of Chicago and healthcare investment firm Deerfield Management announced today the launch of Hyde Park Discovery, a collaboration ...
Crain's Chicago Business3 天
Life sciences investor commits $130M to UChicago drug discovery
After striking similar deals with Northwestern and UIC, Deerfield Management aims to help the University of Chicago turn more ...
The Business Journals3 天
UChicago, Deerfield Management team to accelerate drug discovery and commercialization
Learn more here. New York City investment firm Deerfield Management has committed up to $130 million to launch a collaboration with the University of Chicago aimed at finding new medicines and ...
Le Lézard3 天
The University of Chicago and Deerfield Management launch Hyde Park Discovery to accelerate ...
CHICAGO and NEW YORK, Jan. 28, 2025 /PRNewswire/ -- The University of Chicago and healthcare investment firm Deerfield Management announced today the launch of Hyde Park Discovery, a collaboration ...
kffhealthnews1 天
Ozempic Approved To Treat Chronic Kidney Disease With Type 2 Diabetes
The FDA's move may change how doctors treat chronic kidney disease, which, according to Ozempic maker Novo Nordisk, affects around 37 million Americans and is one of the leading causes of death in the ...